Contribution of peak respiratory exchange ratio to peak VO2 prognostic reliability in patients with chronic heart failure and severely reduced exercise capacity - 28/08/11
, Ugo Corrà, MD a, Enzo Bosimini, MD a, Andrea Giordano b, Pantaleo Giannuzzi, MD aAbstract |
Background |
We evaluated the influence of peak respiratory exchange ratio (pRER), as an index of effort adequacy, on peak VO2 prognostic reliability in patients with chronic heart failure (CHF) and reduced exercise capacity, whose peak VO2 may be underestimated because of poor patient motivation.
Methods |
A cardiopulmonary exercise test was performed in 570 patients with CHF (age 60 ± 10 years, ejection fraction 26% ± 7%, New York Heart Association class 2.2 ± 0.6), 193 of whom had a peak VO2 that was >10 but ≤14 mL/kg/min (reduced exercise capacity) and 80 of whom had a peak VO2 ≤10 mL/kg/min (severely reduced exercise capacity).
Results |
Seventy-eight events (72 cardiovascular deaths and 6 status I heart transplantations) occurred during follow-up (19.6 ± 14 months). The 2-year survival rate was 69% in patients with a peak VO2 ≤10 and 83% in patients with a peak VO2 >10 but ≤14 (P < .0001). However, in the group of patients with a peak VO2 ≤10, patients who had a pRER ≥1.15 had a 2-year survival rate of 52%, and this pRER value (but not ≥1, ≥1.05, or ≥1.10) was the only independent predictor of the composite end point (χ2 = 4.73, P = .03). Conversely, in the group of patients with a peak VO2 ≤10, patients who had a pRER value <1.15 had a survival rate of 83%, which was comparable with that of the group of patients with a peak VO2 >10 but ≤14.
Conclusion |
Patients with CHF and severely reduced exercise capacity should be encouraged to exercise to an RER as close as possible to 1.15, to ascertain their motivation and ensure their peak VO2 prognostic reliability.
Le texte complet de cet article est disponible en PDF.Plan
Vol 145 - N° 6
P. 1102-1107 - juin 2003 Retour au numéro
Article précédent
- Prospective evaluation comparing the effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction
- Lilia Nigro Maia, José Carlos Nicolau, João V Vítola, Márcio Santos, Josélia Menin Brandi, Marcos Rogério Joaquim, José Mário Baggi, José Antonio Cordeiro, Moacir F de Godoy
- Low serum magnesium level predicts major adverse cardiac events after coronary artery bypass graft surgery
- John V Booth, Barbara Phillips-Bute, Charles B McCants, Mihai V Podgoreanu, Peter K Smith, Joseph P Mathew, Mark F Newman
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?